EP3897135A1 - Verfahren zur herstellung eines bioziden, bakterioziden und/oder bakteriostatischen materials - Google Patents
Verfahren zur herstellung eines bioziden, bakterioziden und/oder bakteriostatischen materialsInfo
- Publication number
- EP3897135A1 EP3897135A1 EP19848881.9A EP19848881A EP3897135A1 EP 3897135 A1 EP3897135 A1 EP 3897135A1 EP 19848881 A EP19848881 A EP 19848881A EP 3897135 A1 EP3897135 A1 EP 3897135A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- monomer
- precursor solution
- polymer
- polymer precursor
- biocidal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 60
- 238000000034 method Methods 0.000 title claims abstract description 45
- 230000003115 biocidal effect Effects 0.000 title claims abstract description 38
- 230000003385 bacteriostatic effect Effects 0.000 title claims abstract description 33
- 239000000178 monomer Substances 0.000 claims abstract description 127
- 229920000642 polymer Polymers 0.000 claims abstract description 125
- 239000002243 precursor Substances 0.000 claims abstract description 111
- 150000004032 porphyrins Chemical group 0.000 claims abstract description 34
- 239000010949 copper Substances 0.000 claims abstract description 25
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229910052802 copper Inorganic materials 0.000 claims abstract description 24
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 230000000844 anti-bacterial effect Effects 0.000 claims description 42
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 34
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 claims description 31
- 229950003776 protoporphyrin Drugs 0.000 claims description 31
- 239000002904 solvent Substances 0.000 claims description 28
- 230000008569 process Effects 0.000 claims description 18
- 238000010521 absorption reaction Methods 0.000 claims description 16
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 13
- 150000001412 amines Chemical group 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000006116 polymerization reaction Methods 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 238000010526 radical polymerization reaction Methods 0.000 claims description 10
- 230000004913 activation Effects 0.000 claims description 9
- 239000003999 initiator Substances 0.000 claims description 9
- 239000002798 polar solvent Substances 0.000 claims description 9
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 6
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims description 6
- VZWHXRLOECMQDD-UHFFFAOYSA-L copper;2-methylprop-2-enoate Chemical compound [Cu+2].CC(=C)C([O-])=O.CC(=C)C([O-])=O VZWHXRLOECMQDD-UHFFFAOYSA-L 0.000 claims description 5
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000005470 impregnation Methods 0.000 claims description 4
- 239000011253 protective coating Substances 0.000 claims description 4
- FZGFBJMPSHGTRQ-UHFFFAOYSA-M trimethyl(2-prop-2-enoyloxyethyl)azanium;chloride Chemical group [Cl-].C[N+](C)(C)CCOC(=O)C=C FZGFBJMPSHGTRQ-UHFFFAOYSA-M 0.000 claims description 4
- XPLSDXJBKRIVFZ-UHFFFAOYSA-L copper;prop-2-enoate Chemical compound [Cu+2].[O-]C(=O)C=C.[O-]C(=O)C=C XPLSDXJBKRIVFZ-UHFFFAOYSA-L 0.000 claims description 3
- 238000005202 decontamination Methods 0.000 claims description 3
- 230000003588 decontaminative effect Effects 0.000 claims description 3
- 230000001681 protective effect Effects 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 108
- 239000000976 ink Substances 0.000 description 41
- 150000003254 radicals Chemical class 0.000 description 37
- 150000001875 compounds Chemical class 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 14
- -1 heterocyclic macrocycle Chemical class 0.000 description 14
- 239000011248 coating agent Substances 0.000 description 12
- 238000000576 coating method Methods 0.000 description 12
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 210000004215 spore Anatomy 0.000 description 9
- 125000004386 diacrylate group Chemical group 0.000 description 8
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 8
- 241000193388 Bacillus thuringiensis Species 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 7
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 7
- 229920000742 Cotton Polymers 0.000 description 6
- 241000219146 Gossypium Species 0.000 description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 6
- 239000003899 bactericide agent Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000003330 sporicidal effect Effects 0.000 description 6
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 6
- 229920002554 vinyl polymer Polymers 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 5
- 241000607479 Yersinia pestis Species 0.000 description 5
- 150000001336 alkenes Chemical class 0.000 description 5
- 125000004404 heteroalkyl group Chemical group 0.000 description 5
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 5
- 125000001453 quaternary ammonium group Chemical group 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 210000004666 bacterial spore Anatomy 0.000 description 4
- 125000000753 cycloalkyl group Chemical group 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 125000001072 heteroaryl group Chemical group 0.000 description 4
- 150000002894 organic compounds Chemical class 0.000 description 4
- 239000003504 photosensitizing agent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- 241000193738 Bacillus anthracis Species 0.000 description 3
- 150000003926 acrylamides Chemical class 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- GPRXGEKBQVXWAQ-UHFFFAOYSA-L disodium;3-[18-(2-carboxylatoethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoate Chemical compound [Na+].[Na+].N1C(C=C2C(=C(C)C(=CC=3C(C)=C(CCC([O-])=O)C(N=3)=C3)N2)C=C)=C(C)C(C=C)=C1C=C1C(C)=C(CCC([O-])=O)C3=N1 GPRXGEKBQVXWAQ-UHFFFAOYSA-L 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical group CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 101100272788 Arabidopsis thaliana BSL3 gene Proteins 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000005062 Polybutadiene Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229910001431 copper ion Inorganic materials 0.000 description 2
- 238000003618 dip coating Methods 0.000 description 2
- VFHVQBAGLAREND-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 VFHVQBAGLAREND-UHFFFAOYSA-N 0.000 description 2
- 238000001548 drop coating Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000007641 inkjet printing Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- LQBPATQBTSBIIH-UHFFFAOYSA-N methyl 3-[8,13-bis(ethenyl)-18-(3-methoxy-3-oxopropyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoate Chemical compound N1C(C=C2C(=C(C=C)C(=CC=3C(=C(CCC(=O)OC)C(=C4)N=3)C)N2)C)=C(C=C)C(C)=C1C=C1C(C)=C(CCC(=O)OC)C4=N1 LQBPATQBTSBIIH-UHFFFAOYSA-N 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 238000012009 microbiological test Methods 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000001941 photobactericidal effect Effects 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920002857 polybutadiene Polymers 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 229920001470 polyketone Polymers 0.000 description 2
- 229920000193 polymethacrylate Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- 101150068401 BSL1 gene Proteins 0.000 description 1
- 101150011571 BSL2 gene Proteins 0.000 description 1
- XHIKSLHIZYVEQI-UHFFFAOYSA-N CC1=C(C(=O)[PH2]=O)C(=CC(=C1)C)C Chemical compound CC1=C(C(=O)[PH2]=O)C(=CC(=C1)C)C XHIKSLHIZYVEQI-UHFFFAOYSA-N 0.000 description 1
- 125000006519 CCH3 Chemical group 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000002009 alkene group Chemical group 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N desyl alcohol Natural products C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229910052730 francium Inorganic materials 0.000 description 1
- KLMCZVJOEAUDNE-UHFFFAOYSA-N francium atom Chemical compound [Fr] KLMCZVJOEAUDNE-UHFFFAOYSA-N 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000006713 insertion reaction Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical class [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000004033 porphyrin derivatives Chemical class 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 231100001260 reprotoxic Toxicity 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- AIUAMYPYEUQVEM-UHFFFAOYSA-N trimethyl(2-prop-2-enoyloxyethyl)azanium Chemical group C[N+](C)(C)CCOC(=O)C=C AIUAMYPYEUQVEM-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
- A01N59/20—Copper
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/12—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
Definitions
- the present invention relates to the field of materials, preferably surfaces having biocidal, bactericidal and / or bacteriostatic properties.
- the present application relates to a process for the preparation of a biocidal, bactericidal and / or bacteriostatic material capable of delivering singlet oxygen as a biocidal, bactericidal agent and / or comprising a molecule exhibiting bacteriostatic activity.
- Cellulosic supports such as textiles and fabrics represent an environment conducive to the growth of microorganisms (including bacteria, fungi and viruses).
- photo-sensitizers in particular of the porphyrin type, have the particularity, in the presence of visible light, of releasing singlet oxygen, a reactive species which damages or destroys cells and microorganisms.
- singlet oxygen if the singlet oxygen has not reacted with a cell or a microorganism, it returns to its ground state harmlessly.
- the incorporation of photo-sensitizers into and / or on the surface of a cellulosic support offers the possibility of obtaining surfaces having long-term photo-bactericidal properties and producing no toxic secondary product for its environment. However, this requires chemically grafting, via a covalent bond, the photo-sensitizer onto the support to avoid any phenomenon of release of the active compound.
- porphyrins as a bactericidal agent requires severe conditions (high temperature, use of carcinogens, mutagens and / or reprotoxics). Furthermore, when the support of the material is composed of fibers, such as cellulosic fibers or synthetic fibers, grafting porphyrins requires working on isolated fibers before they are shaped, making the process complex.
- BERTHELOT et al. (W02018 / 069508) have developed a process consisting in modifying a porphyrin so as to introduce an arylazide function which can react with the surface of a support via an insertion reaction.
- the UV irradiation of the modified support makes it possible to obtain a material having antibacterial properties.
- the method of BERTHELOT et al. requires pre-functionalization steps of the photo-sensitizer before it is grafted onto a support.
- the material does not exhibit biocidal activities in the dark, which limits the potential applications of this material.
- At least one of the monomers chosen from: i. a monomer C comprising a quaternary amine and a radical polymerizable function; and or
- a monomer D comprising copper and a radical polymerizable function.
- the invention therefore relates to a process for the preparation of a biocidal, bactericidal and / or bacteriostatic material, said process comprising:
- a monomer C comprising a quaternary amine and a radical polymerizable function
- a monomer D comprising copper and a radical-polymerizable function
- UV irradiation of the polymerization of the precursor solution of polymer impregnated in the support according to step (b), said UV irradiation being carried out at an absorption wavelength less than the wavelength maximum maximum absorption of monomer A;
- the monomer A is a protoporphyrin, preferably the dimethyl ester protoporphyrin or the disodium salt of the protoporphyrin.
- the monomer C is chosen from (meth) acrylates comprising a quaternary amine; preferably is (2- (acryloyloxy) ethyl) trimethylammonium chloride.
- the monomer D is chosen from (meth) acrylates comprising copper or di (meth) acrylates comprising copper; preferably copper acrylate or copper dimethacrylate.
- the photoinitiator has a maximum absorption wavelength of from 350 nm to 400 nm; preferably 360 to 380 nm; more preferably around 365 nm.
- the polymer precursor solution further comprises a solvent, preferably chosen from polar solvents, more preferably a water / ethanol mixture or dimethylsulfoxide (DMSO).
- a solvent preferably chosen from polar solvents, more preferably a water / ethanol mixture or dimethylsulfoxide (DMSO).
- the present invention also relates to a precursor solution of a biocidal, bactericidal and / or bacteriostatic polymer, said solution comprising the mixture of: a. at least one monomer A having a porphyrin group and at least one radical polymerizable function, b. at least one radical polymerizable monomer B, c. a photo-initiator, d. at least one of the monomers chosen from: i. a monomer C comprising a quaternary amine and a radical polymerizable function; and / or ii. a monomer D comprising copper and a radical polymerizable function, e. optionally, a solvent.
- the present invention also relates to a biocidal, bactericidal and / or bacteriostatic material comprising a support impregnated with a polymer matrix resulting from the radical polymerization of a precursor polymer solution as described above.
- the present invention also relates to the use of the polymer precursor solution as described above or of the biocidal, bactericidal and / or bacteriostatic of the invention, for the preparation of protective clothing or protective coatings.
- the polymer precursor solution of the invention or the biocidal, bactericidal and / or bacteriostatic material of the invention is useful for sterilization and / or decontamination of a surface.
- Bactericide refers to any compound or material intended to kill bacteria.
- Bocteriostatic refers to any compound or material capable of inhibiting the multiplication and / or production of bacteria without killing them.
- Biocide refers to any compound or material used to kill, destroy, deteriorate, render harmless, prevent action or combat organisms; preferably single-celled organisms including, for example, eukaryotic or prokaryotic cells.
- the organisms are chosen from bacteria, fungi, viruses and / or yeasts.
- From X to Y refers to the range of values between X and Y, the limits X and Y being included in said range.
- Polymerizable radical function relates to any organic chemical function capable of being involved in a radical polymerization reaction, that is to say capable of providing after activation, at least one active radical species capable to react with the radical polymerizable function of another monomer unit so as to form a single bond, preferably of carbon-carbon or carbon- type oxygen.
- the radical-polymerizable function is chosen from the acrylate, methacrylate, styrenic, vinyl and acrylamide functions.
- UV irradiation relates to any action of light having a wavelength included in the ultraviolet range on a chemical compound or a material.
- “Wavelength” represents the spatial periodicity of the oscillations of an electromagnetic wave, that is to say the distance between two maximum oscillations of an electromagnetic wave.
- the wavelength is expressed in meters (m).
- the expression “absorption wavelength” designates the wavelength of the light after it has passed through a compound or a material.
- max designates the wavelength for which the absorbance is maximum.
- “Monomer” relates, within the meaning of the present invention, to any organic compound having at least one radical polymerizable function, that is to say which is capable of being engaged in a radical polymerization reaction.
- the term “monomer” designates any organic chemical compound comprising one or more functions chosen from acrylates, methacrylates, styrenics, vinyls, and acrylamides, preferably chosen from acrylates and methacrylates.
- the term “monomer” includes the macromolecular chains, preferably obtained by polymerization, comprising at least one radical polymerizable function.
- Photoinitiator relates to any compound capable, under the action of light, of initiating radical polymerization.
- Polymer relates to a material comprising or consisting of one or more macromolecular chains.
- the term “polymer” denotes, in the present invention, the product of a radical polymerization.
- the term “polymer” designates in the present invention the product of a polymerization carried out from monomers as defined above, that is to say from organic compounds having at least one radical polymerizable function including, for example, acrylates, methacrylates, styrenics, vinyls and acrylamides.
- Polymerization relates to any organic reaction leading to the formation of one or more macromolecular chains, each comprising the repetition of a chemical unit.
- the term “polymerization” designates a radical polymerization reaction characterized by a priming step, a propagation step and a termination step, well known to those skilled in the art. According to one embodiment, the term “polymerization” designates a radical polymerization reaction from monomers as defined above.
- Porphyrin designates any compound comprising a heterocyclic macrocycle consisting of four pyrrole subunits joined on their alpha carbons by four methine bridges.
- the term “porphyrin” also includes derivatives of porphyrin, that is to say porphyrins substituted by one or more chemical functions, for example by linear or branched alkyls, alkenes, alkynes, heteroalkyls, carboxylic acids, esters, ketones, aldehydes, hydroxyls, amines and radical polymerizable functions as defined above.
- the term “porphyrin” includes protoporphyrins, their derivatives including protoporphyrins substituted by one or more chemical functions, and their salts such as, for example, the disodium salt of protoporphyrin. According to one embodiment, the term “porphyrin” includes the dimethyl ester protoporphyrin.
- Polymer precursor solution relates to any liquid mixture resulting, after polymerization, in obtaining a polymer as defined above.
- Polar solvent relates to any solvent having a non-zero dipole moment.
- the present invention relates to a process for the preparation of a material, preferably a material having biocidal, bactericidal and / or bacteriostatic properties.
- the material of the invention has a bactericidal and biocidal activity against bacterial spores and / or a bacteriostatic activity.
- the material of the invention generates singlet oxygen as a bactericidal agent.
- the material comprises or consists of a support and a coating.
- the method of the invention is a method of polymerization and / or grafting onto a support, of a coating comprising or consisting of a polymer.
- the method of the invention is a method of polymerization and / or impregnation on a support, of a coating comprising or consisting of a polymer.
- the coating has a biocidal activity against bacterial spores and / or a bacteriostatic activity.
- the coating generates singlet oxygen as a bactericidal agent.
- the method of the invention comprises at least one step of preparing a precursor solution of polymer (also called “ink”) (step noted (a)).
- the polymer precursor solution comprises or consists of the mixture of at least one monomer, preferably at least one monomer A having a porphyrin group and at least one function which can be polymerized by the radical route, with a photo - initiator.
- the polymer precursor solution comprises or consists of the mixture of at least one monomer A having a porphyrin group and at least one radical polymerizable function, at least one monomer B radical polymerizable, and a photo - initiator.
- the monomer A is a porphyrin or one of its derivatives.
- the term "porphyrin derivative” means any substituted porphyrin, preferably any porphyrin substituted on at least one of its pyrrole rings and / or on at least one of its methine bridges.
- the monomer A is a porphyrin substituted with at least one group chosen from alkyl, heteroalkyl, alkene, aryl, heteroaryl, cycloalkyl and any radical polymerizable function such as, for example, acrylate, methacrylate, vinyl, or acrylamide; said group possibly being substituted by at least one substituent chosen from alkyl, heteroalkyl, alkene, aryl, heteroaryl, cycloalkyl, carboxylic acid, hydroxyl, amine and ketone.
- the monomer A is a porphyrin substituted by at least one group chosen from alkyl, heteroalkyl, alkene, aryl, heteroaryl, cycloalkyl and any radical polymerizable function such as, for example, acrylate, methacrylate, styrenic, vinyl, or acrylamide; said group possibly being substituted by at least one substituent chosen from alkyl, heteroalkyl, alkene, aryl, heteroaryl, cycloalkyl, carboxylic acid, hydroxyl, amine and ketone.
- the monomer A is a porphyrin substituted by at least one alkyl group, an alkene group and an alkyl group substituted by a carboxylic function.
- the monomer A is a protoporphyrin or one of its salts and / or derivatives, preferably a protoporphyrin IX, more preferably the monomer A is the dimethyl ester protoporphyrin.
- the term “protoporphyrin salt” means any protoporphyrin for which at least one of the protons of the carboxylic functions of protoporphyrin has been replaced by an alkaline cation such as for example by a lithium ion, (Li +), sodium (Na +), potassium (K +), rubidium (Rb +), Cesium (Cs +) or Francium (Fr +).
- the monomer A is a protoporphyrin salt, preferably the protoporphyrin disodium salt.
- the monomer B is chosen from any organic compound (including compounds of low molar masses and compounds of high molar masses such as macromolecular chains) having at least one function which can be polymerized by radical means, preferably any organic compound having at least one function chosen from acrylates, methacrylates, styrenics, vinyls and acrylamides, preferably chosen from acrylates and methacrylates, more preferably said monomer B is 2- (dimethylamino) ethylacrylate.
- the monomer B is a macromolecular chain having at least one radical polymerizable function; preferably monomer B is a macromolecular chain obtained by any polymerization technique known to a person skilled in the art, and comprising at least one radical polymerizable function; more preferably, said monomer B is a poly (ethylene glycol) chain comprising at least one acrylate or methacrylate function, more preferably said monomer B is poly (ethylene glycol) diacrylate (PEGDA).
- PEGDA poly (ethylene glycol) diacrylate
- the photoinitiator is chosen from those known to those skilled in the art.
- the photoinitiator is a radical photoinitiator, preferably chosen from phosphine oxides, acetophenone and its derivatives, benzoin ethers, benzophenone and its derivatives, thioxanthone and its derivatives, benzyl and its derivatives, more preferably the photoinitiator is dipheny 1 (2,4,6-trimethylbenzoyl) phosphine oxide.
- the photoinitiator has a maximum absorption wavelength less than the maximum absorption wavelength of monomer A, preferably said photoinitiator has a wavelength absorption from 350 nm to 400 nm; preferably 360 to 380 nm; more preferably around 365 nm.
- the precursor polymer solution further comprises at least one compound having a biocidal, bactericidal and / or bacteriostatic activity, partial or total, in the dark.
- the compound having a biocidal, bactericidal and / or bacteriostatic activity, partial or total, in the dark is one of the monomers chosen from: a. a monomer C comprising a quaternary amine and a radical polymerizable function as defined above; and / or b. a monomer D comprising copper and a radical polymerizable function as defined above.
- the monomer C is chosen from (meth) acrylates comprising a quaternary amine, preferably is chosen from (acryloyloxyalkyl) alkylammmonium, more preferably is (2- (acryloyloxy) ethyl) trimethylammonium.
- the monomer C comprises a halogenated counterion, preferably a chloride counterion.
- the monomer D is chosen from (meth) acrylates comprising copper, preferably is a copper acrylate or a dimethacrylate comprising copper, more preferably is copper dimethacrylate (ie ie a complex formed by a copper ion (Cu 2+ ) complexed with two methacrylate molecules).
- the precursor polymer solution consists of or comprises: a. at least one monomer A having a porphyrin group and at least one radical polymerizable function, b. at least one monomer B which can be polymerized by the radical route, vs. a photo-initiator,
- a monomer C comprising a quaternary amine and a radical polymerizable function
- a monomer D comprising copper and a radical polymerizable function.
- the polymer precursor solution comprises the monomer A in a range of more than 0% to 10%, preferably more than 0% to 9%, more than 0% to 8%, more than 0% to 7%, more than 0% to 6%, more than 0% to 5%, more than 0% to 4%, more than 0% to 3%, more than 0% at 2%, or more than 0% to 1%, by weight relative to the total weight of the polymer precursor solution.
- the polymer precursor solution comprises approximately 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9% or 10% of monomer A, the percentages being expressed by weight relative to the total weight of the polymer precursor solution.
- the precursor polymer solution comprises approximately 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0, 8%, 0.9% or 1% of monomer A, the percentages being expressed by weight relative to the total weight of the polymer precursor solution.
- the monomer A when the precursor polymer solution comprises a solvent, the monomer A represents a mass amount of more than 0% to 10%, preferably more than 0% to 1%, by weight relative to the total weight of the polymer precursor solution.
- the polymer precursor solution comprises a solvent
- the monomer A represents a mass quantity approximately equal to 0.1% by weight relative to the total weight of the polymer precursor solution.
- the monomer A when the polymer precursor solution does not comprise a solvent, the monomer A represents a mass amount of more than 0% to 10%, preferably more than 0% to 1%, by weight relative to the total weight of the polymer precursor solution. According to one embodiment, when the polymer precursor solution does not comprise a solvent, the monomer A represents a mass quantity approximately equal to 0.3% by weight relative to the total weight of the polymer precursor solution.
- the precursor polymer solution comprises monomer B in a range of more than 0% to 50%, preferably from 1% to 40%, from 1% to 30%, from 1% to 20%, or from 1% to 10% by weight relative to the total weight of the solution polymer precursor.
- the precursor polymer solution comprises approximately 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13 %, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46% , 47%, 48%, 49% or 50% of monomer B, the percentages being expressed by weight relative to the total weight of the polymer precursor solution.
- the monomer B when the polymer precursor solution does not comprise a solvent, the monomer B represents a mass amount of more than 0% to 50%, by weight relative to the total weight of the polymer precursor solution. According to one embodiment, when the polymer precursor solution comprises a solvent, the monomer B represents a mass amount of more than 0% to 30%, by weight relative to the total weight of the polymer precursor solution. According to one embodiment, when the polymer precursor solution does not comprise a solvent, the monomer B represents a mass quantity approximately equal to 23% or 41% by weight relative to the total weight of the polymer precursor solution. According to one embodiment, when the polymer precursor solution comprises a solvent, the monomer B represents a mass quantity approximately equal to 10% or 20% by weight relative to the total weight of the polymer precursor solution.
- the polymer precursor solution comprises the photoinitiator in a range of more than 0% to 30%, preferably from 1% to 25%, from 1% to 20%, from 1% 15%, 1% to 10%, or 1% to 5% by weight relative to the total weight of the polymer precursor solution.
- the precursor polymer solution comprises the photoinitiator in a mass quantity approximately equal to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26% , 27%, 28%, 29% or 30% by weight relative to the total weight of the polymer precursor solution.
- the photoinitiator represents a mass amount of more than 0% to 30%, preferably from 1% to 20%, by weight relative to the weight total of the polymer precursor solution.
- the photoinitiator represents a mass quantity approximately equal to 13% or 17% by weight relative to the total weight of the polymer precursor solution.
- the photoinitiator when the polymer precursor solution comprises a solvent, the photoinitiator represents a mass amount of more than 0% to 20%, of preferably from 1% to 10%, by weight relative to the total weight of the polymer precursor solution. According to one embodiment, when the polymer precursor solution comprises a solvent, the photoinitiator represents a mass quantity approximately equal to 6% or 7% by weight relative to the total weight of the polymer precursor solution.
- the mass ratio of the monomer C to the monomer D varies from more than 0 to 10, preferably from 1 to 6, more preferably said mass ratio is approximately equal to 4 or 5.
- the mass ratio of the monomer C on the monomer D is approximately equal to 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10.
- the polymer precursor solution comprises the monomer C in a range of more than 0% to 60%, preferably from 1% to 50%, from 1% to 40%, from 1% to 30%, from 1% to 20%, or from 1% to 10%, the percentages being expressed by weight relative to the total weight of the polymer precursor solution.
- the precursor polymer solution comprises approximately 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13 %, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46% , 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59% or 60% of monomer C, by weight relative to the total weight of the polymer precursor solution.
- the monomer C when the polymer precursor solution does not comprise a solvent, the monomer C represents a mass amount of more than 0% to 50%, by weight relative to the total weight of the polymer precursor solution. According to one embodiment, when the polymer precursor solution does not comprise a solvent, the monomer C represents a mass quantity approximately equal to 30%, 38%, 40% or 50% by weight relative to the total weight of the precursor solution of polymer. According to one embodiment, when the polymer precursor solution comprises a solvent, the monomer C represents a mass amount of more than 0% to 30%, by weight relative to the total weight of the polymer precursor solution.
- the monomer C when the precursor polymer solution comprises a solvent, the monomer C represents a mass amount approximately equal to 15%, 17%, 19% or 21% by weight relative to the total weight of the precursor polymer solution .
- the polymer precursor solution comprises the monomer D in a range of more than 0% to 20%, preferably from 1% to 15%, from 1% to 10%, or from 1% at 5% by weight relative to the total weight of the polymer precursor solution.
- the precursor polymer solution comprises approximately 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13 %, 14%, 15%, 16%, 17%, 18%, 19%, or 20%, of monomer D by weight relative to the total weight of the polymer precursor solution.
- the monomer D represents a mass amount of more than 0% to 20%, preferably from 1% to 15%, more preferably from 5% to 12 % by weight relative to the total weight of the polymer precursor solution.
- the monomer D when the polymer precursor solution does not comprise a solvent, the monomer D represents a mass quantity approximately equal to 8% or 10% by weight relative to the total weight of the polymer precursor solution. According to one embodiment, when the precursor polymer solution comprises a solvent, the monomer D represents a mass amount of more than 0% to 10%, preferably from 1% to 8%, by weight relative to the total weight of the polymer precursor solution. According to one embodiment, when the polymer precursor solution comprises a solvent, the monomer D represents a mass quantity approximately equal to 4% by weight relative to the total weight of the polymer precursor solution.
- the precursor polymer solution consists of or comprises:
- a polar solvent preferably dimethyl sulfoxide (DMSO)
- DMSO dimethyl sulfoxide
- the precursor polymer solution consists of or comprises:
- a polar solvent preferably dimethyl sulfoxide (DMSO)
- DMSO dimethyl sulfoxide
- the precursor polymer solution consists of or comprises:
- a polar solvent preferably a water / ethanol mixture
- the precursor polymer solution consists of or comprises:
- a polar solvent preferably dimethyl sulfoxide (DMSO)
- DMSO dimethyl sulfoxide
- the precursor polymer solution consists of or comprises:
- PEGDA polyethylene glycol diacrylate
- a polar solvent preferably dimethylsulfoxide (DMSO)
- the precursor polymer solution consists of or comprises:
- protoporphyrin dimethyl ester or protoporphyrin disodium salt - 0.7 g of polyethylene glycol diacrylate (PEGDA)
- a polar solvent preferably dimethylsulfoxide (DMSO)
- the method of the invention comprises a step of bringing the precursor polymer solution obtained in (a) into contact with a support, resulting in the impregnation of said support with said precursor polymer solution (step noted (b)).
- step (b) is implemented at a temperature of more than 0 ° C to 50 ° C, preferably from 5 ° C to 30 ° C, more preferably at a temperature approximately equal to 20 ° C.
- step (b) is carried out at atmospheric pressure.
- the support can be any support known to a person skilled in the art, including natural or synthetic supports.
- the support can be hard or flexible.
- the support is capable of reacting with at least one radical polymerizable function of a monomer as defined above.
- the support comprises or consists of a cellulosic compound such as, for example, cotton or paper.
- the support comprises or consists of at least one synthetic or natural polymer.
- the support is made of polymer or comprises a polymer, preferably chosen from polystyrenes, polyacrylates, polymethacrylates, polyolefins (such as polyethylene, polypropylene, polybutadiene), polyurethanes, polyacrylamides, polyacrylonitriles, polyamides, polyesters, polyethers, polycarbonates, polyimides, polyketones, polysiloxanes, polyepoxides, and their copolymers and / or their mixtures.
- the natural polymer is chosen from cellulose and rubber (i.e. poly (isoprene)).
- the polymer precursor solution as defined above is applied to the support by any technique known to those skilled in the art including spray (or spraying), soaking, sizing, inkjet printing such as “dip coating” or “drop coating” (coating by drip deposition on the surface of the support).
- step (b) further comprises a drying step.
- step (b) further comprises a washing step.
- step (b) further comprises a step of evaporating the solvent.
- step (b) is implemented in a dark environment, that is to say in an environment protected from light.
- the method of the invention further comprises a step of irradiating the support impregnated with the polymer precursor solution, obtained in step (b).
- the irradiation in step (c) is irradiation by ultraviolet radiation (UV).
- the irradiation, preferably UV is carried out at an absorption wavelength less than the maximum maximum absorption wavelength of the monomer A as described above.
- the irradiation of step (c) is implemented by a UV lamp known by a person skilled in the art, preferably by a UV lamp emitting at a wavelength of about 365 nm.
- the irradiation time of step (c) is more than 0 seconds to 24 hours, preferably from ls to 12h, more preferably from ls to 3600s. According to one embodiment, the irradiation time of step (c) is more than 0 s to 24 h, preferably l s to 12 h, more preferably l s to 3600 s. According to one embodiment, the irradiation time of step (c) is comprised from ls to 60s, preferably from ls to 50s, from ls to 40s, from ls to 30s, from ls to 20s or from ls to 10s.
- the wavelength of the irradiation of step (c) is from 10 nm to 380 nm, preferably from 120 nm to 370 nm, more preferably from 200 nm to 380 nm. According to one embodiment, the wavelength of the irradiation of step (c) is approximately equal to 365 nm. According to one embodiment, the wavelength of the irradiation of step (c) is from 10 nm to 380 nm, preferably from 120 nm to 370 nm, more preferably from 200 nm to 370 nm.
- the absorption wavelength is less than the maximum absorption wavelength lhiac of the monomer A as defined above, preferably is less than 400 nm, more preferably is less than 390 nm, 380nm, or 370 nm.
- the method of the invention further comprises a step of activating the monomer A.
- the activation of the monomer A is implemented by the irradiation of the monomer A , preferably the monomer A having been incorporated into the polymer impregnating the modified support after the implementation of steps (a) to (c) of the process of the invention.
- the activation of the monomer A is implemented by light irradiation, preferably at a wavelength in the visible range, more preferably at the maximum absorption wavelength lhiac porphyrin, more preferably at about 400 nm.
- the activation of the monomer A is implemented for a period of 30 s to 24 h, preferably from 1 min to 12 h, preferably from 2 min to 6 h. According to one embodiment, the activation of the monomer A is implemented for a duration of approximately 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, 9 hours, 10 hours, 1 hour, 12 hours, 1 pm, 2 pm 15h, 16h, 17h, 18h, 19h, 20h, 21h, 22h, 23h or 24h.
- the activation of the monomer A is implemented for a duration of approximately lmn, 2mn, 3mn, 4mn, 5mn, 6mn, 7mn, 8mn, 9mn, lOmn, l lmn, 12mn, 13mn, 14mn , 15mn, 16mn, 17mn, 18mn, 19mn, 20mn, 21mn, 22mn, 23mn, 24mn, 25mn, 26mn, 27mn, 28mn, 29mn, 30mn, 3 lmn, 32mn, 33mn, 34mn, 35mn, 36mn, 37mn, 38mn 39mn, 40mn, 41mn, 42mn, 43mn, 44mn, 45mn, 46mn, 47mn, 48mn, 49mn, 50mn, 5 lmn, 52mn, 53mn, 54mn, 55mn, 56mn,
- the present invention also relates to a precursor solution of a biocidal, bactericidal and / or bacteriostatic polymer, said solution being defined as described above.
- the present invention also relates to a biocidal, bactericidal and / or bacteriostatic material.
- the material of the invention is capable of being obtained by the method of the invention, as described above.
- the material of the invention comprises or consists of a support and a polymer coating, preferably said polymer coating having been obtained from a precursor polymer solution as described above.
- the support can be any support known to a person skilled in the art, including natural or synthetic supports.
- the support can be hard or flexible.
- the support is capable of reacting with at least one radical polymerizable function of a monomer as defined above.
- the support comprises or consists of a cellulosic compound such as, for example, cotton or paper.
- the support is made of polymer or comprises a polymer, preferably chosen from polystyrenes, polyacrylates, polymethacrylates, polyolefins (such as polyethylene, polypropylene, polybutadiene), polyurethanes, polyacrylamides, polyacrylonitriles, polyamides, polyesters, polyethers, polycarbonates, polyimides, polyketones, polysiloxanes, polyepoxides, and their copolymers and / or mixtures thereof.
- the coating is organic, preferably comprises or consists of an organic polymer, more preferably a polymer obtained by radical polymerization, more preferably by radical polymerization from the precursor polymer solution as previously described.
- the coating comprises or consists of one or more macromolecular chains, preferably organic macromolecular chains, more preferably organic macromolecular chains comprising one or more quaternary ammonium functions and / or more copper ions of degree d 'oxidation +11.
- the material or the coating of the invention has a biocidal, bactericidal and / or bacteriostatic activity against Gram positive (Gram +) and / or Gram negative (Gram - type bacteria). ), preferably against Escherichia coli (Gram -), Bacillus thuringiensis (Gram +) in vegetative form (bacterial form), Yersinia pestis (Gram -) and / or Bacillus anthracis (Gram +) vegetative, as well as form sporulate of B. thuringiensis. Indeed, certain bacterial species like B. thuringiensis are capable of sporulating.
- bacterial spores means a multilayer microbial form extremely resistant to environmental disturbances (nutritive stress, desiccation, heat, radiation, antibiotics, antiseptics and standard disinfectants, etc.). This resistance is notably linked to their unique structure which is particularly compact and not very permeable.
- the invention also relates to the use of the polymer precursor solution, of the material or of the process of the invention, as described above.
- the polymer precursor solution, the material or the method of the invention are useful in the field of textiles or protective coatings, or in the sanitary field.
- the polymer precursor solution, the material or the method of the invention are useful for the preparation of protective clothing or protective coatings.
- the polymer precursor solution of the invention or the biocidal, bactericidal and / or bacteriostatic material of the invention is useful for the sterilization and / or decontamination of a surface.
- the invention also relates to a kit for implementing the method of the invention.
- the kit comprises at least one compartment comprising the polymer precursor solution as described above.
- the kit comprises:
- a second compartment comprising the photoinitiator.
- the kit comprises:
- the kit is opaque and does not allow light to pass through.
- PBS Phosphate Buffered Saline
- PEGDA polyethylene glycol diacrylate
- UV ultraviolet
- ink D comprising copper but no ammonium
- ink E comprising ammonium but no copper.
- Example 2 Process for the preparation of a biocidal, bactericidal and / or bacteriostatic material
- the support was impregnated with the ink by any of the following techniques: spray, soaking, sizing, inkjet printing, “dip coating” or “drop coating” (coating by drip deposit on the surface of the support).
- the supports impregnated with the ink were then irradiated under UV at a wavelength of around 365 nm (UVKURE 120 LED lamp - 365 nm, 1.5 kW, 12W / cm 2 , Kelenn Technology, Lrance ). Both sides of the support can be irradiated.
- the irradiation time of each face of the support is between 2 s to 1 min.
- the materials grafted with the inks are, before grafting, washed with water, then washed with ethanol then autoclaved (130 ° C. for 20 min) before to perform microbiology tests.
- microbiological tests were also carried out on autoclaved materials after grafting. 2 1: Protocols for carrying out microbiology tests
- microbiological tests were carried out using the following bacterial strains:
- the protocol applied to the vegetative cells consists in the implementation of the following steps:
- the aim is to obtain an initial culture which corresponds to a bacterial culture in the exponential phase at 10 6 CFU (Colony Forming Unit) / ml which is used for the contamination of the materials to be tested.
- Example: DO 0.4 with E. coli.
- another test protocol consists in subjecting the petri dishes containing the discs to natural light for 30 seconds in a room where the temperature is regulated at 22 ° C.
- the discs are placed in sterile petri dishes with a tissue soaked in water (humid atmosphere).
- One of the boxes is exposed to light, the other is put in the dark (covered with aluminum foil).
- the exposure to light is carried out, for the exposure time of 30 seconds, by subjecting the Petri dishes containing the disks to natural light for 30 seconds in a room where the temperature is regulated; for exposure times of 24h, lh, 30 min or 5 min by incubation at 30 ° C in an incubator with the lighting system with standard LED 4000K (Lexman Light 230 V, E14, 470 Lumen).
- PBS Phosphate Buffered Saline
- the spore solutions are produced and stored in distilled water. Their stability is evaluated every month using a limit dilution count. The concentration of spores used in these tests is 10 5 CLU / mL.
- the discs are placed in sterile petri dishes with a tissue soaked in water (humid atmosphere).
- the inoculum volume for contamination is 30pL.
- One of the boxes is exposed to light, the other is in the dark (covered with aluminum foil). Spores are exposed to transplanted discs for 24 hours.
- the extraction of the spores from the samples is carried out according to a protocol similar to that applied to the vegetative cells, except the use of distilled water in place of PBS and the addition of a 30 second sonication step. before incubation for 30 minutes with shaking.
- the enumeration protocol is identical to that of vegetative cells, except for the use of distilled water in place of PBS.
- the results indicate that the inks B and C have a total bactericidal activity from 30 seconds of contact, whether in light or in the dark on Gram + bacteria (B. thuringiensis) and Gram- (E. coli).
- BSL3 laboratory tests demonstrate the bactericidal activity of ink C on the agents B. anthracis and Y. pestis in 5 min. In addition, this activity is not altered after an autoclaving cycle (130 ° C for 20 min) of the treated discs.
- Table 4 Results of the bacterial tests carried out using materials obtained with autoclaved inks B and C after grafting.
- Table 5 Tests relating to the sporicidal activity of the materials obtained with inks B and C.
- the ink C was broken down and each component was grafted separately.
- model bacterium chosen for this test was a Gram + bacterium, B. thuringiensis.
- Table 6 Bactericidal effect in the light and in the dark of materials impregnated with one of the inks A, C, D or E.
- Table 7 Sporicidal effect in the light and in the dark of materials impregnated with one of the inks A, C, D or E.
- Table 8 Bactericidal effect in the light and in the dark of materials impregnated with ink F.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Toxicology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Polymerisation Methods In General (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1873328A FR3090271B1 (fr) | 2018-12-19 | 2018-12-19 | Procédé de préparation d’un matériau biocide, bactéricide et/ou bactériostatique |
PCT/FR2019/053185 WO2020128350A1 (fr) | 2018-12-19 | 2019-12-19 | Procédé de préparation d'un matériau biocide, bactéricide et/ou bactériostatique |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3897135A1 true EP3897135A1 (de) | 2021-10-27 |
EP3897135B1 EP3897135B1 (de) | 2022-12-07 |
Family
ID=66530260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19848881.9A Active EP3897135B1 (de) | 2018-12-19 | 2019-12-19 | Verfahren zur herstellung eines bioziden, bakterioziden und/oder bakteriostatischen materials |
Country Status (4)
Country | Link |
---|---|
US (1) | US20220053766A1 (de) |
EP (1) | EP3897135B1 (de) |
FR (1) | FR3090271B1 (de) |
WO (1) | WO2020128350A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3110589B1 (fr) * | 2020-05-20 | 2024-02-02 | Commissariat Energie Atomique | Procédé et solution pour préparer une surface à activité bactériostatique et bactéricide, surface ainsi préparée et ses utilisations |
CN112832028B (zh) * | 2021-02-05 | 2023-06-30 | 浙江红督服饰有限公司 | 一种丝绸天然抗菌布料的制备方法 |
CN115850884B (zh) * | 2022-12-27 | 2024-03-19 | 义乌市希福防护用品有限公司 | 一种具有抗菌功能的隔离防护面具材料的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2749854A1 (fr) * | 1996-06-13 | 1997-12-19 | Biogical | Procede de fabrication de polymeres bactericides et produits obtenus par ce procede |
FR2846970B1 (fr) * | 2002-11-08 | 2006-08-11 | Desarrollo Del Grafting S L | Procede de traitement de surface par photopolymerisation pour obtenir des proprietes biocides |
EP3308646B1 (de) | 2016-10-14 | 2020-10-07 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Photoaktivierbare biozide und/oder bakterizide materialien und verfahren zur herstellung derartiger materialien |
US10561146B2 (en) * | 2017-11-28 | 2020-02-18 | International Business Machines Corporation | Star polymers with enhanced antimicrobial activity in response to light |
-
2018
- 2018-12-19 FR FR1873328A patent/FR3090271B1/fr active Active
-
2019
- 2019-12-19 US US17/415,368 patent/US20220053766A1/en active Pending
- 2019-12-19 EP EP19848881.9A patent/EP3897135B1/de active Active
- 2019-12-19 WO PCT/FR2019/053185 patent/WO2020128350A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
EP3897135B1 (de) | 2022-12-07 |
WO2020128350A1 (fr) | 2020-06-25 |
FR3090271A1 (fr) | 2020-06-26 |
FR3090271B1 (fr) | 2021-03-05 |
US20220053766A1 (en) | 2022-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3897135B1 (de) | Verfahren zur herstellung eines bioziden, bakterioziden und/oder bakteriostatischen materials | |
Galstyan et al. | Boronic acid functionalized photosensitizers: a strategy to target the surface of bacteria and implement active agents in polymer coatings | |
Muthuchamy et al. | Anti-biofilm investigation of graphene/chitosan nanocomposites against biofilm producing P. aeruginosa and K. pneumoniae | |
Han et al. | Immobilization of amphiphilic polycations by catechol functionality for antimicrobial coatings | |
Dai et al. | Kill–resist–renew trinity: hyperbranched polymer with self-regenerating attack and defense for antifouling coatings | |
Chemburu et al. | Light-induced biocidal action of conjugated polyelectrolytes supported on colloids | |
Glaive et al. | Design of antibacterial and sustainable antioxidant networks based on plant phenolic derivatives used as delivery system of carvacrol or tannic acid | |
Park et al. | One‐step, painting‐like coating procedures to make surfaces highly and permanently bactericidal | |
Su et al. | Initiated chemical vapor deposition of graded polymer coatings enabling antibacterial, antifouling, and biocompatible surfaces | |
Lu et al. | BODIPY-based macromolecular photosensitizer with cation-enhanced antibacterial activity | |
Liu et al. | Antimicrobial property of halogenated catechols | |
CN102131836A (zh) | 抗菌聚合物及涂料 | |
Tang et al. | Preparation of a porphyrin metal–organic framework with desirable photodynamic antimicrobial activity for sustainable plant disease management | |
Alvarez et al. | Photodynamic inactivation of Candida albicans using bridged polysilsesquioxane films doped with porphyrin | |
WO2004044040A1 (fr) | Procede de traitement de surface par photopolymerisation pour obtenir des proprietes biocides | |
CA2759846C (fr) | Support d'information presentant des proprietes antivirales et son procede de fabrication | |
CA2481443C (fr) | Support d'information presentant des proprietes biocides et son procede de fabrication | |
Wang et al. | Antimicrobial activity of cationic conjugated polyelectrolytes and oligomers against Saccharomyces cerevisiae vegetative cells and ascospores | |
Reynoso et al. | Photoactive antimicrobial coating based on a PEDOT-fullerene C 60 polymeric dyad | |
EP3380536A1 (de) | Polymere zusammensetzung | |
CN113855844B (zh) | 一种抗菌材料及其制备方法和应用 | |
EP0591024B1 (de) | Antiseptisches Polymer | |
Maldonado-Carmona et al. | Latest trends on photodynamic disinfection of Gram-negative bacteria: Photosensitizer’s structure and delivery systems | |
Baigorria et al. | Potentiation effect of iodine species on the antimicrobial capability of surfaces coated with electroactive phthalocyanines | |
Tempesti et al. | Poly (propylene)-based films modified with a tetracationic phthalocyanine with applications in photodynamic inactivation of Candida albicans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210719 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) Owner name: CONSERVATOIRE NATIONAL DES ARTS ET METIERS Owner name: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20220715 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 1535734 Country of ref document: AT Kind code of ref document: T Effective date: 20221215 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602019022998 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20221207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230307 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1535734 Country of ref document: AT Kind code of ref document: T Effective date: 20221207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230308 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230410 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20221231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221219 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230407 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602019022998 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221219 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 |
|
26N | No opposition filed |
Effective date: 20230908 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231220 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20231222 Year of fee payment: 5 Ref country code: DE Payment date: 20231214 Year of fee payment: 5 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221207 |